Please login to the form below

Not currently logged in
Email:
Password:

Poxel

This page shows the latest Poxel news and features for those working in and with pharma, biotech and healthcare.

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Metavant/Poxel prep phase 3 for imeglimin in diabetic kidney disease

Treatment can help patients with advanced disease, companies say. Emboldened by new clinical data, French biotech Poxel and partner Metavant are planning a phase 3 programme in the US and Europe ... Imeglimin is thought to work against mitochondrial

Latest news

  • After Axovant shock, Roivant pens diabetes deal with Poxel After Axovant shock, Roivant pens diabetes deal with Poxel

    Hard on the heels of the Axovant news, parent company Roivant announced that it had signed a development and licensing deal with French biotech Poxel for imeglimin, a candidate originally discovered ... Poxel says imeglimin is in a new class of oral

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics